Abstract
Pulmonary pleomorphic carcinoma with choriocarcinomatous differentiation is an extremely rare and highly malignant tumor. We report a case in a 39-year-old female discovered after a metastatic duodenal tumor caused severe hemorrhage. Following surgical resection of both the primary and metastatic sites, serum human chorionic gonadotropin (hCG) levels normalized, and the patient achieved a stable recovery.
Introduction
Pulmonary pleomorphic carcinoma (PC) is a rare subtype of non-small cell lung cancer (NSCLC), accounting for approximately 0.3% of all lung tumors. It is characterized by a mixture of spindle cells, giant cells, and epithelial components. A further rarity is choriocarcinomatous differentiation, where the tumor produces human chorionic gonadotropin (hCG), mimicking gestational choriocarcinoma. These tumors are highly aggressive and often present at an advanced stage due to early metastasis, making early diagnosis and treatment a significant clinical challenge.
Case Presentation
A 39-year-old female presented with symptoms of severe anemia. Diagnostic workup, including endoscopy and imaging, revealed a bleeding tumor in the duodenum and a concurrent solid mass in the right lower lobe of the lung.
Biopsies from both sites showed similar poorly differentiated tumor cells, leading to a diagnosis of lung cancer with duodenal metastasis. The patient underwent a two-stage surgical intervention: first, a partial duodenal resection to control the life-threatening hemorrhage, followed three months later by a thoracoscopic right lower lobectomy.
Pathological Analysis and Results
Histological analysis of the resected tissues confirmed a heterogeneous tumor containing giant cells, spindle cells, and syncytiotrophoblast-like cells. Immunohistochemistry was strongly positive for β-hCG, confirming the choriocarcinomatous nature of the tumor. The final diagnosis was pT2N0M1 Stage IV pleomorphic carcinoma with choriocarcinomatous differentiation. Post-operatively, serum hCG levels plummeted from 1953 mIU/ml to 1.5 mIU/ml within 18 days, indicating successful removal of the hormone-producing tumor mass.
Discussion
This case highlights the aggressive nature of PC and its potential for unusual metastatic sites. While lung cancer frequently spreads to the brain, bones, or liver, symptomatic small intestine metastasis is rare, occurring in about 18% of autopsies but seldom diagnosed in living patients. The production of hCG serves as a valuable biochemical marker for both diagnosis and monitoring treatment response. Furthermore, this case suggests that aggressive surgical resection of both primary and metastatic lesions can be a viable strategy for local control in Stage IV disease, particularly when acute complications like hemorrhage are present and the primary site is localized (N0).
Conclusion
hCG-producing pulmonary pleomorphic carcinoma is a high-grade malignancy with a poor prognosis. Early detection is often difficult due to rapid metastasis. In cases with localized primary tumors and manageable metastatic complications, aggressive surgical intervention may offer significant clinical benefits and improve quality of life.
Summary updated